Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerezyme Dosing Frequency in Type 1 Gaucher Disease
NCT00364858Phase 4Completed
- Sponsor
- Sanofi
- Start
- Dec 2001
- Modality
- Replacement Enzymes
- Countries
- 7
01
Overview
A Phase 4 trial of imiglucerase in Gaucher disease type 1 (GD1), sponsored by Sanofi. Started Dec 2001; status: completed.
02
Drugs
imiglucerase
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on NCT00364858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364858.